Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹289Cr
Rev Gr TTM
Revenue Growth TTM
12.31%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

YASHOPTICS
VS
| Quarter | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | | | -5.9 | 13.0 | 4.4 | 5.7 | 19.9 |
| 14 | 14 | 12 | 15 | 14 | 17 | 18 |
Operating Profit Operating ProfitCr |
| 31.4 | 31.4 | 37.1 | 34.2 | 30.4 | 28.1 | 21.9 |
Other Income Other IncomeCr | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Interest Expense Interest ExpenseCr | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Depreciation DepreciationCr | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
| 6 | 6 | 6 | 7 | 7 | 8 | 6 |
| 1 | 1 | 1 | 1 | 2 | 2 | 1 |
|
Growth YoY PAT Growth YoY% | | | 7.0 | 18.0 | 6.1 | 6.5 | -31.4 |
| 20.2 | 20.2 | 23.0 | 21.1 | 23.3 | 21.3 | 13.3 |
| 0.0 | 0.0 | 0.0 | 0.0 | 1.9 | 2.0 | 1.3 |
| Financial Year | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| | 98.8 | 33.5 | 3.5 | 5.1 | 9.0 |
| 13 | 20 | 27 | 27 | 31 | 35 |
Operating Profit Operating ProfitCr |
| 13.7 | 34.4 | 31.4 | 35.5 | 29.1 | 25.0 |
Other Income Other IncomeCr | 0 | 0 | 0 | 0 | 3 | 3 |
Interest Expense Interest ExpenseCr | 1 | 1 | 1 | 2 | 1 | 1 |
Depreciation DepreciationCr | 0 | 1 | 1 | 1 | 1 | 2 |
| 1 | 9 | 11 | 12 | 13 | 13 |
| 0 | 2 | 3 | 3 | 3 | 3 |
|
| | 541.2 | 17.8 | 12.4 | 6.3 | -14.9 |
| 7.1 | 22.9 | 20.2 | 21.9 | 22.2 | 17.3 |
| 0.6 | 3.9 | 8,028.0 | 18.8 | 3.9 | 3.3 |
| Financial Year | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Equity Capital Equity CapitalCr | 0 | 0 | 0 | 18 | 25 |
| 4 | 11 | 19 | 12 | 66 |
Current Liabilities Current LiabilitiesCr | 2 | 9 | 3 | 13 | 8 |
Non Current Liabilities Non Current LiabilitiesCr | 6 | 4 | 12 | 17 | 13 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 12 | 20 | 26 | 33 | 70 |
Non Current Assets Non Current AssetsCr | 0 | 5 | 8 | 27 | 42 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | 0 | 8 | -12 | -12 | 6 |
Investing Cash Flow Investing Cash FlowCr | 0 | -5 | -8 | -19 | -37 |
Financing Cash Flow Financing Cash FlowCr | 0 | -3 | 10 | 31 | 31 |
|
Free Cash Flow Free Cash FlowCr | 0 | 3 | -20 | -25 | -6 |
| -5.0 | 113.2 | -151.2 | -137.3 | 59.2 |
CFO To EBITDA CFO To EBITDA% | -2.6 | 75.5 | -97.3 | -84.9 | 45.1 |
| Financial Year | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 0 | 0 | 0 | 0 | 199 |
Price To Earnings Price To Earnings | 0.0 | 0.0 | 0.0 | 0.0 | 20.7 |
Price To Sales Price To Sales | 0.0 | 0.0 | 0.0 | 0.0 | 4.6 |
Price To Book Price To Book | 0.0 | 0.0 | 0.0 | 0.0 | 2.2 |
| 2.4 | 0.3 | 0.8 | 1.7 | 14.4 |
Profitability Ratios Profitability Ratios |
| 31.6 | 64.0 | 63.2 | 67.0 | 65.8 |
| 13.7 | 34.4 | 31.4 | 35.5 | 29.1 |
| 7.1 | 22.9 | 20.2 | 21.9 | 22.2 |
| 19.7 | 64.5 | 39.7 | 25.1 | 13.5 |
| 24.9 | 61.7 | 42.1 | 30.2 | 10.6 |
| 8.8 | 27.9 | 23.6 | 14.9 | 8.6 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
Yash Optics & Lens Limited is a vertically integrated Indian provider of vision correction solutions. The company has successfully transitioned from a pure trading and import entity into a high-tech manufacturer specializing in **digital freeform progressive lenses**. With a robust portfolio of **36 brands** and an exclusive partnership with global leader **HOYA**, the company is positioning itself as a primary beneficiary of the "Make in India" initiative within the precision optics sector.
---
### **Manufacturing Infrastructure & Backward Integration**
The company has strategically shifted its operational model toward **backward integration** to reduce dependency on imports from China, Japan, and South Korea. This transition is anchored by two primary facilities:
| Facility Location | Primary Function | Strategic Significance |
| :--- | :--- | :--- |
| **Kandivali (W), Mumbai** | Core Manufacturing & HQ | **ISO 9001:2015** certified; houses manufacturing, warehousing, and management. |
| **Vapi, Gujarat** | Lens Casting (New) | Commenced **April 2026**; focuses on finished and semi-finished lens blanks. |
* **Production Capacity:** The Vapi facility currently produces **10,000 pairs per day**, with a roadmap to scale to **20,000 pairs** via marginal capital expenditure.
* **Technological Edge:** The company utilizes advanced European machinery, including **Schneider** freeform machines (imported May 2025) and **IOT/Pentax** designer software. These upgrades have increased progressive lens capacity by **60%**.
* **Operational Efficiency:** Yash Optics maintains an industry-leading turnaround time, delivering prescription lenses within **24-48 hours** of order placement.
---
### **Comprehensive Product Portfolio & Market Segmentation**
Yash Optics serves a diverse demographic, ranging from economy to luxury segments, through a hybrid model of manufacturing and branded distribution.
#### **Core Lens Categories**
* **Single Vision Lenses:** Corrects myopia and hypermetropia; targeted at ages **0–35**.
* **Bifocal Lenses:** Dual-surface lenses for near and distant vision; targeted at ages **>35**.
* **Progressive Lenses:** Advanced multifocal designs with smooth transitions; targeted at ages **>45**.
* **Specialty Solutions:** Includes **Mirror**, **Polarized**, and **Lifestyle** lenses, featuring **Integrated Blue Light Protection** for digital strain and **Adaptive Technology** for UV/sunlight responsiveness.
#### **Strategic Brand & Distribution Assets**
* **Exclusive Partnership:** Yash is the **sole distributor** for **"Pentax"** ophthalmic lenses in India under an agreement with **HOYA Lens India Pvt. Ltd.**
* **Proprietary Brands:** Owns and markets **36 brands**, including the premium **IRIS** and **Seto** lines.
* **B2C Transformation:** Transitioning from B2B to a household name through the **LUSTRAA** brand, supported by high-visibility advertising on the **Western and Southern Railway** networks.
---
### **Strategic Growth Pillars & "Make in India" Roadmap**
Following its **April 2024 IPO** (raising **₹53.15 crore**), the company is executing a multi-pronged growth strategy:
* **Import Substitution:** Shifting from international sourcing to in-house "blanks" manufacturing at the Vapi plant to improve supply chain agility and margins.
* **Geographical Expansion:** Deepening its footprint in **Maharashtra, Gujarat, and Rajasthan** while targeting export markets in the **Asia-Pacific and Latin America**. (FY 2024-25 exports: **₹5.32 crore**).
* **Future-Tech Diversification:** R&D is focused on high-growth sectors beyond traditional eyewear:
* **Automotive:** Precision optics for **ADAS** and **Head-Up Displays (HUDs)**.
* **Consumer Electronics:** Lenses for **AR/VR/MR** wearables.
* **Healthcare:** High-resolution imaging for **endoscopy and microscopy**.
---
### **Financial Performance & Capital Structure**
The company’s financial profile reflects a period of significant capital expansion and improving operational leverage.
**Key Financial Metrics (FY 2024-25 vs. FY 2023-24)**
| Metric | FY 2024-25 (₹ Cr) | FY 2023-24 (₹ Cr) | Growth (%) |
| :--- | :--- | :--- | :--- |
| **Revenue from Operations** | **43.21** | **41.11** | **5.08%** |
| **Total Income** | **46.04** | **41.20** | **11.76%** |
| **Profit After Tax (PAT)** | **9.59** | - | - |
| **PAT Margin** | **20.82%** | - | - |
| **Net Capital Turnover Ratio** | **2.07** | **1.77** | **17.20%** |
* **Profitability:** The **Net Profit Ratio** improved to **21.95%**. **Return on Capital Employed (ROCE)** stands at a healthy **24.97%**.
* **Cost Management:** Raw materials account for **33%** of total income, while employee benefits represent **16.09%**.
* **Capital Base:** Following the IPO, the paid-up share capital increased to **₹24.77 crore**. As of January 2025, **₹18.25 crore** of IPO proceeds remained unutilized, earmarked for further technological upgrades.
---
### **Risk Profile & Mitigation Framework**
Yash Optics operates in a high-barrier-to-entry market but faces specific regulatory and competitive headwinds.
* **Regulatory Disputes:** The company is currently contesting a **Directorate of Revenue Intelligence (DRI)** inquiry regarding **Anti-Dumping Duty (ADD)** on a "Fully Automatic DUV Laser" machine. Management maintains that ADD is not applicable based on legal counsel.
* **Market Competition:** Faces intense price pressure from global players and emerging startups. The company mitigates this by focusing on the high-margin **Progressive Lens** segment and exclusive technology partnerships.
* **Intellectual Property:** While the company secured exclusive rights to key trademarks from promoters at **no monetary cost**, it remains vigilant against patent infringement and counterfeiting.
* **Internal Controls:** The company utilizes a structured framework aligned with **ICAI Guidance Notes** to ensure statutory compliance, asset protection, and accurate financial reporting.
---
### **Investment Summary**
Yash Optics & Lens Limited represents a specialized play on the Indian vision care market. With the commissioning of the **Vapi facility**, the company has moved from being a distributor to a manufacturer with significant **operating leverage**. Its ability to double its **Progressive Lens business** and successfully integrate its new casting operations will be the primary drivers of long-term shareholder value.